Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This reflects a minor software update to the page rather than changes to the trial details.
    Difference
    0.1%
    Check dated 2026-08-29T23:45:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new Study Protocol and Statistical Analysis Plan PDF was added to the Study Documents section, provided by the University of Pittsburgh; the file size is 0.73 MB.
    Difference
    59%
    Check dated 2026-08-15T23:56:13.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - The page revision in the footer updated from v3.6.4 to v3.6.5. This reflects a new build/version of the page without changing substantive content.
    Difference
    0.1%
    Check dated 2026-08-08T20:53:49.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision label now shows v3.6.4, indicating a new site version has been deployed.
    Difference
    0.1%
    Check dated 2026-07-25T12:49:37.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3. This indicates a newer page revision rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:49:45.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.0 to v3.6.2, indicating a minor maintenance or template update. There are no changes to study details, eligibility criteria, or results content.
    Difference
    0.1%
    Check dated 2026-06-26T20:04:27.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.